Navigation Links
New MRI finding sheds light on multiple sclerosis disease progressio
Date:8/27/2007

OAK BROOK, Ill. Using magnetic resonance (MR) images of the brain, researchers have identified a new abnormality related to disease progression and disability in patients with multiple sclerosis (MS), according to a study published in the August issue of Radiology.

Based on these findings, physicians may be able to diagnose multiple sclerosis more accurately and identify patients at risk for developing progressive disease, said the studys lead author, Rohit Bakshi, M.D., associate professor of neurology and radiology at Harvard Medical School and director of clinical MS-MRI at Brigham and Womens Hospital and Partners MS Center in Boston.

MS is a chronic, autoimmune disease characterized by the destruction of myelin, the protective layers that surround nerve cells. It can affect numerous body functions, and symptoms may include visual and speech impairment, memory loss, depression, muscle weakness, loss of coordination, numbness, pain, bowel and bladder problems and sexual dysfunction.

MS affects approximately 400,000 people in the United States and as many as 2.5 million worldwide, mostly women between the ages of 20 and 50, according to the National Multiple Sclerosis Society.

There are four classifications of MS, but the two most common types are relapsing-remitting and secondary-progressive. Patients with relapsing-remitting MS will experience symptom flare-ups followed by periods of no disease progression. Patients with secondary- progressive MS exhibit an initial period of relapsing-remitting MS, followed by steady disease progression.

Dr. Bakshi and colleagues retrospectively reviewed the T1 MRI data of 145 MS patients, including 112 women and 33 men. Ninety-two patients had relapsing-remitting MS, and 49 patients had secondary-progressive MS. The disease classification was unknown in four patients.

The researchers found that T1-weighted MR images of the brains of MS patients often depict bright ar
'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7738
Radiological Society of North America
Source:Eurekalert

3

GOOD

Page: 1 2

Related medicine news :

1. Gujarat quake-Rescue teams give up hope of finding more survivors
2. Finding The Key To Weight Loss!
3. Fat findings
4. Finding relief from Excruciating Headaches a challenge
5. Latest Findings On The Deadly Disease - SARS
6. New Findings Could Reduce The Extent Of Spinal Cord Injuries
7. Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option
8. New Findings for Repeated Miscarriages
9. New findings come to light about monkeypox
10. Internet Helps Patients In Finding Info About Their Childrens Health Conditions
11. Researchers finding link between malaria susceptibility and genetic makeup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...: The National AIDS Control Organization (NACO) ha...ng 54, to provide free anti-retroviral treatment (...h 9 more centers on the anvil. These centers will...0 patients, who will avail the services of exclusi...
...f its continued efforts to give back to the cancer...al scientific meetings//, the Fairfax, Virginia-ba... Oncology (ASTRO) is partnering with Cancer Hope N...p. The Cancer Hope Network is a non-profit organiz...
...tereotypical self-image as the “strong, silent typ...why older men //are less likely than women to be r...t for depression, and to recognize and express sym...recruiters interviewed for a new study from the UC...
...rs at the George Institute for International Healt... disease is the number one killer in rural India. ...urvey in Andhra Pradesh. The findings of the surve...pidemiology this week. The report said India needs...
Other Medicine News:Health News:Cancer Hope Network, ASTRO Partner to Raise Awareness of Cancer Survivorship 2Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 2Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 3Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 4Health News:Chronic Diseases Rampant In Rural India 2
(Date:8/26/2008)...wire/ -- The Oregon Tourism Commission,launched it...aining Program,(Q Care) this week on http://www.O...gram created to support the tourism and,hospitalit... emphasizing,the importance of quality customer se...s and resources to better serve Oregon,s visitors....
(Date:8/26/2008)...swire/ -- Semafore Pharmaceuticals Inc.,announced ...ss on Targeted,Therapies in Cancer in Washington, ...f vascular-targeted PI3 kinase (PI3K) inhibitor SF...I3K is part of a very powerful pathway, the PI3/AK...r role in cancer. Studies have shown that by,inhib...
(Date:8/26/2008)...n drive safely six weeks following surgical,treatm...re/ -- Six weeks following,bunion surgery, most pa...to,get back behind the wheel of a car again. A stu...al of Bone and Joint Surgery ( http://www.jbjs.org...in patients who underwent a,first metatarsal osteo...
(Date:8/26/2008)...wswire/ -- Cambridge Research &,Instrumentation, I... EX In,Vivo Imaging System. The new system incorpo...ecomes the entry-level instrument of choice for in...newscom.com/cgi-bin/prnh/20080826/NETU054 ), FLE...of CRi,s unique,solid-state tunable optics that fo...
Breaking Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Braking After Bunion Surgery 2Braking After Bunion Surgery 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2How cancer spreads by aggregating platelets 192 1How cancer spreads by aggregating platelets 192 2How cancer spreads by aggregating platelets 192 3New Treatment Explored for Cluster Headaches 246 1New Treatment Explored for Cluster Headaches 246 2New Treatment Explored for Cluster Headaches 246 3Wolves find happy hunting grounds in Yellowstone National Park 189 1Wolves find happy hunting grounds in Yellowstone National Park 189 2Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 1Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 2Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 3Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 4
...mic Analyses of School and Daycare Study Outcomes ...e Cost Savings for,Community at Large, TORONTO..., Inc.,announced today research results showing ...Live, Intranasal) in daycare and school,settings... Economic,analyses applied to outcomes observed ...
...entific Presentation for Pristiq Occurs at the 55t...of Obstetricians and,Gynecologists, COLLEGEVILLE, ...Pharmaceuticals, a division of Wyeth , presented r...ristiq(TM) (desvenlafaxine) for,the treatment of m...and night sweats) associated with menopause. These...
Other Medicine Technology:Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 2Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 3Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 4Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 5Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 6Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 7Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 8Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6
Streck-Detergent III is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured for the Abbott CELL-DYN® 1400, 1600, 3500 and 3700. The shelf life
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer.
...us Retics is a 5-part differential control that co...r the Abbott CELL-DYN 3200, 3500, 3700 and 4000 in...ated red blood cells that can be analyzed and enum...tomated and manual reticulocyte values for all thr...
Para 12 Plus is a hematology control for the Abbott CELL-DYN 3000, 3200, and 3500/3700. Assay values are provided for the five-part white cell differential, as well as a three-part differential on th
Medicine Products: